Submission Details
| 510(k) Number | K981913 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 01, 1998 |
| Decision Date | February 12, 1999 |
| Days to Decision | 256 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K981913 is an FDA 510(k) clearance for the PREVUE(TM) BORRELIA BURGDORFERI ANTIBODY DETECTION ASSAY, a Reagent, Borrelia Serological Reagent (Class II — Special Controls, product code LSR), submitted by Chembio Diagnostic Systems, Inc. (Stoneybrook, US). The FDA issued a Cleared decision on February 12, 1999, 256 days after receiving the submission on June 1, 1998. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3830.
| 510(k) Number | K981913 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 01, 1998 |
| Decision Date | February 12, 1999 |
| Days to Decision | 256 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | LSR — Reagent, Borrelia Serological Reagent |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.3830 |